Literature DB >> 34260328

Platelet-leukocyte interactions in the pathogenesis of viral infections.

Eugenio D Hottz1,2, Anna Cecíllia Quirino-Teixeira1, Laura Botelho Merij1, Mariana Brandi Mendonça Pinheiro1, Stephane Vicente Rozini1, Fernando A Bozza3,4, Patrícia T Bozza2.   

Abstract

Evolving evidence demonstrates that platelets have major roles in viral syndromes through previously unrecognized viral sensing and effector functions. Activated platelets and increased platelet-leukocyte aggregates are observed in clinical and experimental viral infections. The mechanisms and outcomes of platelet-leukocyte interactions depend on the interacting leukocyte as well as on the pathogen and pathological conditions. In this review, we discuss the mechanisms involved in platelet interactions with leukocytes and its functions during viral infections. We focus on the contributions of human platelet-leukocyte interactions to pathophysiological and protective responses during viral infections of major global health relevance, including acquired immunodeficiency syndrome (AIDS), dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), influenza pneumonia, and COVID-19.

Entities:  

Keywords:  COVID-19; Dengue; HIV; Influenza; platelet-leukocyte aggregates; platelets

Mesh:

Year:  2021        PMID: 34260328     DOI: 10.1080/09537104.2021.1952179

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  5 in total

1.  Platelet proteome reveals features of cell death, antiviral response and viral replication in covid-19.

Authors:  Monique R O Trugilho; Isaclaudia G Azevedo-Quintanilha; João S M Gesto; Emilly Caroline S Moraes; Samuel C Mandacaru; Mariana M Campos; Douglas M Oliveira; Suelen S G Dias; Viviane A Bastos; Marlon D M Santos; Paulo C Carvalho; Richard H Valente; Eugenio D Hottz; Fernando A Bozza; Thiago Moreno L Souza; Jonas Perales; Patrícia T Bozza
Journal:  Cell Death Discov       Date:  2022-07-16

Review 2.  Platelet-Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases.

Authors:  Kinga Pluta; Kinga Porębska; Tomasz Urbanowicz; Aleksandra Gąsecka; Anna Olasińska-Wiśniewska; Radosław Targoński; Aleksandra Krasińska; Krzysztof J Filipiak; Marek Jemielity; Zbigniew Krasiński
Journal:  Biology (Basel)       Date:  2022-01-30

3.  Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation.

Authors:  Kai Jakobs; Leander Reinshagen; Marianna Puccini; Julian Friebel; Anne-Christin Beatrice Wilde; Ayman Alsheik; Andi Rroku; Ulf Landmesser; Arash Haghikia; Nicolle Kränkel; Ursula Rauch-Kröhnert
Journal:  Front Immunol       Date:  2022-03-11       Impact factor: 7.561

4.  A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score.

Authors:  Hannah Schaefer; Albert Rübben; André Esser; Arturo Araujo; Oana-Diana Persa; Marike Leijs
Journal:  PLoS One       Date:  2022-08-25       Impact factor: 3.752

Review 5.  Prothrombotic Phenotype in COVID-19: Focus on Platelets.

Authors:  Cristina Barale; Elena Melchionda; Alessandro Morotti; Isabella Russo
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.